📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review (2022)

First Author: Drennan P

Attributed to: Therapeutic targeting of fibroblast subsets in inflammatory arthritis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cts.13457

PubMed Identifier: 36420645

Publication URI: http://europepmc.org/abstract/MED/36420645

Type: Journal Article/Review

Parent Publication: Clinical and Translational Science

Issue: 3

ISSN: 1752-8054